Fintel reports that on January 22, 2025, Canaccord Genuity initiated coverage of Orthofix Medical (NasdaqGS:OFIX) with a Buy ...

Canaccord Genuity initiates coverage on Orthofix Medical with a Buy rating and $24 price target, citing growth potential and strong financial outlook.

Comparatively, Orthofix Medical has a beta of 1.1, meaning that its share price is 10% more volatile than the S&P 500. 99.1% of AtriCure shares are owned by institutional investors. Comparatively ...

Julie Andrews, Orthofix's CFO, sold 4,655 shares of common stock on Jan. 16, according to a Jan. 21 SEC filing.

Corporate crises happen—and that means we have to plan for them. While it isn’t practical to prepare for every possible corporate crisis, there ...

GET MORE AI-GENERATED SIGNALS: January 16, 2025, 22:48 pm ET, BY Bill T.- Contributor| Editor: Thomas H. Kee Jr. ( Follow on ...

DelveInsight Analysis: The Orthopedic Trauma Devices market size is expected to grow at a CAGR of 6.43% during the forecast period (201-26) to reach USD 10.08 billion by 2030. Which MedTech key ...

Berkshire Hathaway company focused on plastic and upper extremity surgery, is pleased to announce the appointment of Remco Maljers as its Head of International Sales.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Biosurgery Market worth $16.0 ...